Apixaban for Secondary Prevention of Thromboembolism Among Patients With AntiphosPholipid Syndrome
Clinical trial NCT02295475 · COMPLETED
Trial details
- NCT number
- NCT02295475
- Sponsor
- Scott C. Woller, MD
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-10
- Primary completion
- 2020-04-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.